3D Medicines Inc. is a leading innovative biopharmaceutical company and committed to the development and commercialization of next generation of immuno-oncology (I/O) therapies with differentiated clinical benefit in response to the trend of treating cancer as a chronic disease. The mission is to help prolong the survival of cancer patients and improve their quality of life. The visionary management team has led us to build industry-leading, fully-integrated capabilities in end-to-end drug R&D from pre-clinical discovery to clinical development and commercialization. The core product envafolimab is a global first and only BLA-stage, subcutaneously-injectable PD-L1 antibody that has the potential to address a global unmet medical need for the treatment of cancer as a chronic disease. With a robust I/O monotherapy and combo-therapy portfolio of more than 10 drug candidates with envafolimab as the backbone, we strive to become a leader in the chronic cancer treatment market.
For more information, please visit www.3d-medicines.com.
Company Details
- Employees
- 75
- Founded
- -
- Address
- Furonghua Rd, Pudong New District, Bldg11,no.118,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.3d-medicines.com/
- Keywords
- 上海市.
- HQ
- Shanghai
3d Medicines Inc Questions
3D Medicines Inc's website is https://www.3d-medicines.com/
3D Medicines Inc's LinkedIn profile is https://www.linkedin.com/company/3d-medicines-inc
3D Medicines Inc has
75 employees.
View email and phone details for 75
employees at 3D Medicines Inc.
3D Medicines Inc's industry is
Pharmaceutical Manufacturing
3D Medicines Inc's top competitors are
Suzhou Shengji Intelligent Equipment Co.,ltd,
上海海雁医药科技有限公司,
Ignis Therapeutics (Shanghai) Co., Ltd,
上海岸迈生物科技有限公司,
3dmedcare,
Visby Medical,
益方生物 Inventisbio,
Nuvation Bio,
Amgen,
Genfleet Therapeutics.
3D Medicines Inc's categories are Pharmaceutical Manufacturing
3D Medicines Inc's founding year is 2018
